Rapid assessment of cardiovascular risk among users of smoking cessation drugs within the US Food and Drug Administration's Mini-Sentinel program.
Publication
, Journal Article
Toh, S; Baker, MA; Brown, JS; Kornegay, C; Platt, R; Mini-Sentinel Investigators
Published in: JAMA Intern Med
May 13, 2013
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JAMA Intern Med
DOI
EISSN
2168-6114
Publication Date
May 13, 2013
Volume
173
Issue
9
Start / End Page
817 / 819
Location
United States
Related Subject Headings
- Varenicline
- United States Food and Drug Administration
- United States
- Tobacco Use Disorder
- Smoking Cessation
- Sentinel Surveillance
- Risk Factors
- Risk Assessment
- Quinoxalines
- Product Surveillance, Postmarketing
Citation
APA
Chicago
ICMJE
MLA
NLM
Toh, S., Baker, M. A., Brown, J. S., Kornegay, C., Platt, R., & Mini-Sentinel Investigators. (2013). Rapid assessment of cardiovascular risk among users of smoking cessation drugs within the US Food and Drug Administration's Mini-Sentinel program. JAMA Intern Med, 173(9), 817–819. https://doi.org/10.1001/jamainternmed.2013.3004
Toh, Sengwee, Meghan A. Baker, Jeffrey S. Brown, Cynthia Kornegay, Richard Platt, and Mini-Sentinel Investigators. “Rapid assessment of cardiovascular risk among users of smoking cessation drugs within the US Food and Drug Administration's Mini-Sentinel program.” JAMA Intern Med 173, no. 9 (May 13, 2013): 817–19. https://doi.org/10.1001/jamainternmed.2013.3004.
Toh S, Baker MA, Brown JS, Kornegay C, Platt R, Mini-Sentinel Investigators. Rapid assessment of cardiovascular risk among users of smoking cessation drugs within the US Food and Drug Administration's Mini-Sentinel program. JAMA Intern Med. 2013 May 13;173(9):817–9.
Toh, Sengwee, et al. “Rapid assessment of cardiovascular risk among users of smoking cessation drugs within the US Food and Drug Administration's Mini-Sentinel program.” JAMA Intern Med, vol. 173, no. 9, May 2013, pp. 817–19. Pubmed, doi:10.1001/jamainternmed.2013.3004.
Toh S, Baker MA, Brown JS, Kornegay C, Platt R, Mini-Sentinel Investigators. Rapid assessment of cardiovascular risk among users of smoking cessation drugs within the US Food and Drug Administration's Mini-Sentinel program. JAMA Intern Med. 2013 May 13;173(9):817–819.
Published In
JAMA Intern Med
DOI
EISSN
2168-6114
Publication Date
May 13, 2013
Volume
173
Issue
9
Start / End Page
817 / 819
Location
United States
Related Subject Headings
- Varenicline
- United States Food and Drug Administration
- United States
- Tobacco Use Disorder
- Smoking Cessation
- Sentinel Surveillance
- Risk Factors
- Risk Assessment
- Quinoxalines
- Product Surveillance, Postmarketing